Differences in Regional Cerebral Blood Flow Patterns in Male versus Female Patients with Alzheimer Disease

References

1. ↵
   Buckwalter JG, Sobel E, Dunn ME, et al. Gender differences on a brief measure of cognitive functioning in Alzheimer’s disease. Arch Neurol 1993;50:757–760

   CrossRefPubMedWeb of Science
2. Henderson VW, Buckwalter JG. Cognitive deficits of men and women with Alzheimer’s disease. Neurology 1994;44:90–96

   Abstract/FREE Full Text
3. Ripich DN, Petrill SA, Whitehouse PJ, Ziol EW. Gender differences in language of AD patients: a longitudinal study. Neurology 1995;45:299–302

   Abstract/FREE Full Text
4. Buckwalter JG, Rizzo AA, McCleary R, et al. Gender comparisons of cognitive performances among vascular dementia, Alzheimer disease, and older adults without dementia. Arch Neurol 1996;53:436–439

   CrossRefPubMedWeb of Science
5. ↵
   McPherson S, Back C, Buckwalter JG, Cummings JL. Gender-related cognitive deficits in Alzheimer’s disease. Int Psychogeriatr 1999;11:117–122

   CrossRefPubMed
6. ↵
   Nitrini R, Buchpiguel CA, Caramelli P, et al. SPECT in Alzheimer’s disease: features associated with bilateral parietotemporal hypoperfusion. Acta Neurol Scand 2000;101:172–176

   CrossRefPubMed
7. ↵
   Ott BR, Heindel WC, Tan Z, Noto RB. Lateralized cortical perfusion in women with Alzheimer’s disease. J Gend Specif Med 2000;3:29–35
8. ↵
   Swaltz RH, Black SE, Leibovitch FS, et al. Sex and mental status, but not apolipoprotein E, correlate with parietal and temporal hypoperfusion on SPECT in Alzheimer’s disease [abstract]. Neurology 1998;50:A159
9. ↵
   Small GW, Kuhl DE, Riege WH, et al. Cerebral glucose metabolic patterns in Alzheimer’s disease: effect of gender and age at dementia onset. Arch Gen Psychiatry 1989;46:527–532

   CrossRefPubMedWeb of Science
10. ↵
    Minoshima S, Frey KA, Koeppe RA, et al. A diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995;36:1238–1248

    Abstract/FREE Full Text
11. ↵
    Bartenstein P, Minoshima S, Hirsch C, et al. Quantitative assessment of cerebral blood flow in patients with Alzheimer’s disease by SPECT. J Nucl Med 1997;38:1095–1101

    Abstract/FREE Full Text
12. Hirsch C, Bartenstein P, Minoshima S, et al. Reduction of regional cerebral blood flow and cognitive impairment in patients with Alzheimer’s disease: evaluation of an observer-independent analytic approach. Dement Geriatr Cogn Disord 1997;8:98–104

    CrossRefPubMedWeb of Science
13. ↵
    Hanyu H, Shimizu T, Tanaka Y, et al. Regional cerebral blood flow patterns and response to donepezil treatment in patients with Alzheimer’s disease. Dement Geriatr Cogn Disord 2003;15:177–182

    PubMedWeb of Science
14. ↵
    Hanyu H, Shimizu T, Tanaka Y, et al. Effects of age on regional cerebral blood flow patterns in Alzheimer’s disease patients. J Neurol Sci 2003;209:25–30

    CrossRefPubMed
15. ↵
    McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984;34:939–944

    Abstract/FREE Full Text
16. ↵
    Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198

    CrossRefPubMedWeb of Science
17. ↵
    Talairach J, Tournoux P. Co-Planar Stereotactic Atlas of the Human Brain. New York: Thieme;1998
18. ↵
    Minoshima S, Koeppe RA, Frey KA, Kuhl DE. Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med 1994;35:1528–1537

    Abstract/FREE Full Text
19. ↵
    Fazekas C, Chawluk JB, Alavi A, et al. MR signal abnormality at 1.5T in Alzheimer’s dementia and normal aging. AJR Am J Roentogenol 1987;149:351–356

    CrossRefPubMedWeb of Science
20. ↵
    Scheltens PH, Leys D, Barkhof F, et al. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992;55:967–972

    Abstract/FREE Full Text
21. ↵
    Kidron D, Black SE, Stanchev P, et al. Quantitative MR volumetry in Alzheimer’s disease: topographic markers and the effects of sex and education. Neurology 1997;49:1504–1512

    Abstract/FREE Full Text
22. ↵
    Salat DH, Stangl PA, Kaye JA, Janowsky JS. Sex differences in prefrontal volume with aging and Alzheimer’s disease. Neurobiol Aging 1999;20:591–596

    CrossRefPubMedWeb of Science
23. ↵
    Smith CD, Pettigrew LC, Avison MJ, et al. Frontal lobe phosphorus metabolism and neuropsychological function in aging and in Alzheimer’s disease. Ann Neurol 1995;38:194–201

    CrossRefPubMedWeb of Science
24. ↵
    Jones K, Johnson KA, Becker A, et al. Use of singular value decomposition to characterize age and gender differences in SPECT cerebral perfusion. J Nucl Med 1998;39:965–973

    Abstract/FREE Full Text
25. ↵
    Gur RC, Mozley LH, Mozley PD, et al. Sex differences in regional cerebral glucose metabolism during a resting state. Science 1995;267:528–531

    Abstract/FREE Full Text
26. ↵
    Andreason PJ, Zametkin AJ, Guo AC, et al. Gender-related differences in regional cerebral glucose metabolism in normal volunteers. Psychiatry Res 1993;51:175–183

    CrossRef
27. ↵
    George MS, Ketter TA, Parekh PI, et al. Gender differences in regional cerebral blood flow during transient self-induced sadness or happiness. Biol Psychiatry 1996;40:859–871

    CrossRefPubMedWeb of Science
28. Kawachi T, Ishii K, Sakamoto S, et al. Gender differences in cerebral glucose metabolism: a PET study. J Neurol Sci 2002;199:79–83

    CrossRefPubMedWeb of Science
29. ↵
    Murphy DGM, DeCarli C, McIntosh AR, et al. Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Arch Gen Psychiatry 1996;53:685–594
30. ↵
    Ragland JD, Coleman AR, Gur RC, et al. Sex differences in brain- behavior relationships between verbal episodic memory and resting regional cerebral blood flow. Neuropsychologia 2000;38:451–461

    CrossRefPubMedWeb of Science
31. ↵
    Ghebremedhin E, Schultz C, Thal DR, et al. Gender and age modify the association between APOE and AD-related neuropathology. Neurology 2001;56:1696–1701

    Abstract/FREE Full Text
32. ↵
    Sandberg G, Stewart W, Smialek J, Troncoso JC. The prevalence of the neuropathological lesions of Alzheimer’s disease is independent of race and gender. Neurobiol Aging 2001;22:169–175

    CrossRefPubMedWeb of Science
33. ↵
    Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease: the Baltimore longitudinal study of aging. Neurology 1997;48:1517–1521

    Abstract/FREE Full Text
34. ↵
    Tang MX, Jacobs D, Stern Y, et al. Effect of estrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet 1996;348:429–432

    CrossRefPubMedWeb of Science
35. ↵
    Shamma FN, Fayad P, Brass L, Sarrel P. Middle cerebral artery blood velocity during controlled ovarian hyperstimulation. Fertil Steril 1992;5:1022–1025
36. ↵
    Ohkura T, Isse K, Akazawa K, et al. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr J 1994;41:361–371

    PubMedWeb of Science